BESST:英国校园青少年压力简易CBT工作坊的临床与成本效果集群随机试验
BESST集群随机对照试验在57所英国学校纳入900名16-18岁自述受压力困扰的青少年,比较DISCOVER简短CBT工作坊与常规治疗。
要点
- 在每QALY 2万至3万英镑阈值下,DISCOVER具有成本效果的概率为61%-78%。
- 两组不良事件分别为9例和14例,严重不良事件各2例,安全性总体可接受。
核心结论
- DISCOVER简短CBT工作坊对16-18岁青少年压力相关抑郁症状具有轻度临床效果且经济可行,可作为学校早期干预的候选方案。
研究设计与样本
- 多中心、集群随机对照试验,在英国具有六年级的学校或学院开展,按1:1随机分为DISCOVER工作坊组与常规治疗组,按站点分层并平衡学校规模和多重剥夺指数。
- 计划纳入60所学校900名青少年,通过自我转介系统招募;实际纳入57所学校900名参与者,DISCOVER组443人、常规治疗组457人。
- 纳入标准为16-18岁、全年在校、因压力寻求帮助、英语流利并能提供书面知情同意;结局评估者、高级卫生经济学家、高级统计师和主要研究者设盲。
- 主要结局为6个月随访时用情绪与感受问卷(MFQ)测量的抑郁症状,在意向性治疗人群中分析所有具有完整协变量数据的参与者。
- 试验注册号ISRCTN90912799。
主要发现
- 900名参与者中873人(97%)完成意向性治疗人群随访。
- DISCOVER组报告9例不良事件(其中2例为严重不良事件),常规治疗组报告14例不良事件(其中2例为严重不良事件)。
- 在每质量调整生命年(QALY)2万至3万英镑阈值下,DISCOVER相较常规治疗具有成本效果的概率为61%至78%。
关键数值与推荐
- 成本效果概率在每QALY 2万至3万英镑阈值下为61%至78%。
临床怎么用
- 在学校环境中,DISCOVER简短CBT工作坊可作为16-18岁青少年压力相关抑郁症状的早期干预选项,但效应量较小,需结合个体评估使用。
- 该干预在每QALY 2万至3万英镑阈值下具有中等偏高的成本效果概率,可为学校心理健康资源配置提供参考。
局限性
- 原文未报告
- 原文未报告
- 原文未报告
- 原文未报告
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Depression and anxiety are increasingly prevalent in adolescents. The Brief Educational Workshops in Secondary Schools Trial investigated the effectiveness of a brief accessible stress workshop programme for 16-18-year-olds. We aimed to investigate the clinical effectiveness and cost-effectiveness of the DISCOVER cognitive behavioural therapy (CBT) workshop on symptoms of depression in 16-18-year-olds at 6 months compared with treatment-as-usual. METHODS: We conducted a multicentre, cluster randomised controlled trial in UK schools or colleges with sixth forms to evaluate clinical effectiveness and cost-effectiveness of a brief CBT workshop (DISCOVER) compared with treatment-as-usual. We planned to enrol 60 schools and 900 adolescents, using a self-referral system to recruit participants. Schools were randomised in a 1:1 ratio for participants to receive either the DISCOVER workshop or treatment-as-usual, stratified by site and balanced on school size and index of multiple deprivation. Participants were included if they were 16-18 years old, attending for the full school year, seeking help for stress, and fluent in English and able to provide written informed consent. The outcome assessors, senior health economist, senior statistician, and chief investigator were masked. People with lived experience were involved in the study. The primary outcome was depression symptoms measured with the Mood and Feelings Questionnaire (MFQ) at 6-month follow-up, in the intention-to-treat population of all participants with full covariate data. The trial was registered with the ISRCTN registry (ISRCTN90912799). FINDINGS: 111 schools were invited to participate in the study, seven were deemed ineligible, and 47 did not provide consent. Between Oct 4, 2021, and Nov 10, 2022, 933 students at 57 schools were screened for eligibility, seven were not eligible for inclusion, and 26 did not attend the baseline meeting and assessment, resulting in 900 adolescents participating in the study. The DISCOVER group included 443 participants (295 [67%] female and 136 [31%] male) and the treatment-as-usual group included 457 participants (346 [76%] female and 92 [20%] male). 468 (52%) of the 900 participants were White, and the overall age of the participants was 17·2 years (SD 0·6). 873 (97%) adolescents were followed up in the intention-to-treat population. The primary intention-to-treat analysis (n=854) found an adjusted mean difference in MFQ of -2·06 (95% CI -3·35 to -0·76; Cohen's d=-0·17; p=0·0019) at the 6-month follow-up, indicating a clinical improvement in the DISCOVER group. The probability that DISCOVER is cost- effective compared with treatment-as-usual ranged from 61% to 78% at a £20 000 to £30 000 per quality-adjusted life-year threshold. Nine adverse events (two of which were classified as serious) were reported in the DISCOVER group and 14 (two of which were classified as serious) were reported in the treatment-as-usual group. INTERPRETATION: Our findings indicate that the DISCOVER intervention is modestly clinically effective and economically viable and could be a promising early intervention in schools. Given the importance of addressing mental health needs early in this adolescent population, additional research is warranted to explore this intervention. FUNDING: National Institute for Health and Care Research Health Technology Assessment Programme.
引用
- Brown J, James K, Lisk S, et al. Clinical effectiveness and cost-effectiveness of a brief accessible cognitive behavioural therapy programme for stress in school-aged adolescents (BESST): a cluster randomised controlled trial in the UK. Lancet Psychiatry. 2024. PMID: 38759665. doi:10.1016/S2215-0366(24)00101-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。